Drug
Trans-sodium crocetinate clinical trials
Also written TSC and Trans Sodium Crocetinate.
How studies write it
Studies that test it under each name
Studies by the year they started
10 studies that test it; most in 2021 (3)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 1
Diffusion Pharmaceuticals Inc (9) · Catholic University of Pelotas (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
Studies
Open first, then newest update. How each study uses trans-sodium crocetinate is read from its arms, and is right about nine times in ten.
Testing it · 10
- Safety and Efficacy of Trans Sodium Crocetinate (TSC) in Enhancing Tissue Oxygen Levels in Healthy VolunteersCompletedPhase 1Diffusion Pharmaceuticals IncNCT04808622Written as Trans-Sodium Crocetinate
- Study of Trans Sodium Crocetinate in Patients With Interstitial Lung DiseaseTerminatedPhase 2Diffusion Pharmaceuticals IncNCT05079126Written as Trans Sodium Crocetinate
- Safety and Efficacy of Trans Sodium Crocetinate (TSC) in SARS-CoV-2 (COVID-19) Infected SubjectsCompletedPhase 1/2Diffusion Pharmaceuticals IncNCT04573322Written as Trans Sodium Crocetinate
- Randomized, Double-Blind, Placebo-Controlled, Crossover Study of Trans Sodium Crocetinate in Healthy Volunteers Exercising at AltitudeCompletedPhase 1Diffusion Pharmaceuticals IncNCT05036980Written as Trans Sodium Crocetinate
- Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) in Newly Diagnosed Glioblastoma (GBM) Biopsy-Only SubjectsTerminatedPhase 3Diffusion Pharmaceuticals IncNCT03393000Written as Trans Sodium Crocetinate plus SOC
- Efficacy and Safety of Trans Sodium Crocetinate (TSC) for Treatment of Suspected StrokeTerminatedPhase 2Diffusion Pharmaceuticals IncNCT03763929Written as Trans-Sodium Crocetinate
- Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed GlioblastomaCompletedPhase 1/2Diffusion Pharmaceuticals IncNCT01465347Written as Trans Sodium Crocetinate (TSC)
- Comparative Effectiveness of 30%TSC and Heparin Lock Solution in Hemodialysis CathetersCompletedPhase 4Catholic University of PelotasNCT02563041Written as 30% TSC
- Safety, Efficacy, and Pharmacokinetics (PK) Study of Trans Sodium Crocetinate (TSC) in Patients With Intermittent ClaudicationCompletedPhase 1/2Diffusion Pharmaceuticals IncNCT00725881Written as Trans sodium crocetinate (TSC)
- Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade GliomaTerminatedPhase 1Diffusion Pharmaceuticals IncNCT00826930Written as Trans Sodium Crocetinate (TSC)
Codes
What other systems call trans-sodium crocetinate · ClinicalTrials.gg INT004667
- MeSH (NLM) C487773trans-sodium crocetinateConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 20TC155L9CTRANSCROCETINConfirmed FDA, NLM, Wikidata
- Wikidata Q2714546crocetinConfirmed FDA, NLM, Wikidata
- DrugBank DB05974One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C487773 | trans-sodium crocetinate | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 20TC155L9C | TRANSCROCETIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q2714546 | crocetin | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB05974 | — | One source Wikidata |
Also registered as transcrocetinate sodium (UNII YP57637WMX).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.